Jelle Barentsz, MD, presented “The Capacity of MRI to Predict Extracapsular Disease​” for the Grand Rounds in Urology audience during a break at the 30th Annual International Prostate Cancer Update in January, 2020.

How to cite: Barentsz, Jelle. “The Capacity of MRI to Predict Extracapsular Disease” January, 2020. Accessed Dec 2021.​/

The Capacity of MRI to Predict Extracapsular Disease – Summary:

Jelle Barentsz, MD, PhD, Professor of Radiology at the Nijmegen Medical Center of Radboud University in Nijmegen, The Netherlands, discusses the capacity of MRIs to predict extracapsular disease. He notes that this is not a perfect technology and it is not possible to predict with one hundred percent accuracy, but he emphasizes how it can be useful for staging. He also discusses when it is necessary to wait and how long to wait after a biopsy for a staging MRI.  Lastly, he covers situations where it is not necessary to wait for an MRI.

About The 30th Annual International Prostate Cancer Update:

The International Prostate Cancer Update (IPCU), founded in 1990, is a multi-day CME conference focused on prostate cancer treatment updates with expert, international faculty. It is led by expert physicians and is designed for urologists, medical oncologists, radiation oncologists, and other healthcare professionals involved in the diagnosis and treatment of prostate cancer. Dr. Barentsz & Dr. Crawford discussed this topic during a break at the 30th iteration of the meeting in January 2020.

Other parts of this interview include:

What Does Suspicion for Prostate Cancer Mean, and What Metric Defines Prostate Cancer Risk?

Are MRI Fusion Biopsies Necessary for Urologists?

For further educational activities from this conference, visit our collection page.